Evidence map›Paper›PMID 30181656›Full record

ArticleScientific reports2018

Two-Dimensional Proton Magnetic Resonance Spectroscopy versus J-Editing for GABA Quantification in Human Brain: Insights from a GABA-Aminotransferase Inhibitor Study.

Andrew P Prescot, James J Prisciandaro, Steven R Miller, Gary Ingenito, Douglas G Kondo, Perry F Renshaw

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. High-resolution, 3D multi-TEMagnetic resonance in medicine · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Andrew P PrescotDepartment of Radiology and Imaging Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA. andrew.prescot@utah.edu.
James J PrisciandaroDepartment of Psychiatry and Behavioral Sciences, Addiction Sciences Division, Medical University of South Carolina, Charleston, SC, USA.
Steven R MillerCatalyst Pharmaceuticals Inc, Coral Gables, FL, USA.
Gary IngenitoCatalyst Pharmaceuticals Inc, Coral Gables, FL, USA.
Douglas G KondoDepartment of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Perry F RenshawDepartment of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Catalyst Pharmaceuticals (United States) · USMental Illness Research, Education and Clinical Centers · USMedical University of South Carolina · USUniversity of Utah · US

Funding

MENTORING IN DRUG ABUSE NEUROIMAGINGK24DA015116 · NIDA · UNIVERSITY OF UTAH · PI RENSHAW, PERRY FRANKLIN · 2002 to 2010
$1.3M
NIDA NIH HHS K24 DA015116
6 · The paper itself

Abstract

Metabolite-specific, scalar spin-spin coupling constant (J)-editing

Indexed as

4-Aminobutyrate TransaminaseAdolescentAdultBrainEnzyme Inhibitorsgamma-Aminobutyric AcidHumansMaleMiddle AgedProlineProton Magnetic Resonance SpectroscopyYoung Adult(1S,3S)-3-amino-4-difluoromethylenecyclopentanecarboxylic acid4-Aminobutyrate TransaminaseEnzyme Inhibitorsgamma-Aminobutyric AcidProline

Identifiers

PMID30181656
PMCPMC6123452
OpenAlexW2889021122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.